psilocybin has been researched along with Psychotic Disorders in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (75.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (6.25) | 24.3611 |
| 2020's | 3 (18.75) | 2.80 |
| Authors | Studies |
|---|---|
| Basu, A; Belal, S; Jacob, T; Suleiman, M | 1 |
| Barber, G; Nemeroff, CB; Siegel, S | 1 |
| De Pieri, M; Kaiser, S; Kirschner, M; Langlest, F; Mallet, L; Perez, N; Sabé, M; Sentissi, O; Seragnoli, F; Solmi, M; Thorens, G; Zullino, D | 1 |
| Carhart-Harris, RL; Erritzoe, D; Evans, J; Feilding, A; Leech, R; Nutt, DJ; Sharp, DJ; Stone, JM; Williams, TM; Wise, RG | 1 |
| HEIMANN, H | 2 |
| GROF, S; VITEK, V; VOJTECHOVSKY, M | 1 |
| RYSANEK, K; VITEK, V; VOJTECHOVSKY, M | 1 |
| LINGL, FA; TOLAN, EJ | 1 |
| LEUNER, H | 1 |
| PELICIER, Y | 1 |
| LEVINE, J; LUDWIG, AM | 1 |
| MIYOSHI, A | 1 |
| Johnsen, G | 1 |
| Laffont, F; Lelord, G | 1 |
| Hole, G | 1 |
2 review(s) available for psilocybin and Psychotic Disorders
| Article | Year |
|---|---|
Psilocybin-assisted therapy for depression: A systematic review and dose-response meta-analysis of human studies.
Topics: Adult; Antidepressive Agents; Depression; Humans; Psilocybin; Psychotic Disorders; Randomized Controlled Trials as Topic | 2023 |
[LSD and related hallucinogens. History--effect--use and dangers].
Topics: Autonomic Nervous System; Cannabis; Chemistry; Culture; Hallucinogens; History, 20th Century; Humans; Lysergic Acid Diethylamide; Mescaline; Psilocybin; Psychotic Disorders | 1967 |
14 other study(ies) available for psilocybin and Psychotic Disorders
| Article | Year |
|---|---|
From Mushrooms to Myolysis: A Case of Rhabdo in Psilocybin-Induced Mood and Psychotic Disorder.
Topics: Agaricales; Humans; Psilocybin; Psychotic Disorders; Rhabdomyolysis; Substance-Related Disorders | 2022 |
A Case of Prolonged Mania, Psychosis, and Severe Depression After Psilocybin Use: Implications of Increased Psychedelic Drug Availability.
Topics: Depression; Depressive Disorder, Major; Hallucinogens; Humans; Mania; Psilocybin; Psychotic Disorders | 2022 |
Functional connectivity measures after psilocybin inform a novel hypothesis of early psychosis.
Topics: Adult; Cerebral Cortex; Cerebrum; Connectome; Female; Hallucinogens; Humans; Male; Nerve Net; Psilocybin; Psychoses, Substance-Induced; Psychotic Disorders; Reproducibility of Results; Thalamus; Young Adult | 2013 |
[Expressive phenomenology of model psychoses (psilocybin). Comparison with self-description and psychic deficiency of performance].
Topics: Hallucinogens; Indoles; Mental Disorders; Psilocybin; Psychotic Disorders | 1961 |
[On the treatment of therapy-resistant neuroses with model psychoses (psilocybin)].
Topics: Hallucinogens; Mental Disorders; Neurotic Disorders; Psilocybin; Psychotic Disorders | 1962 |
[Serotonin metabolism in experimental psilocybin psychosis].
Topics: Biochemical Phenomena; Hallucinogens; Indoles; Mental Disorders; Psilocybin; Psychotic Disorders; Serotonin | 1961 |
[Effect of neurohormone precursors from the amino acid group on experimental psychoses induced with Psilocybine].
Topics: Amino Acids; Hallucinogens; Methionine; Neurotransmitter Agents; Psilocybin; Psychotic Disorders; Serotonin | 1962 |
"MODEL PSYCHOSIS" PRODUCED BY INHALATION OF GASOLINE FUMES.
Topics: Adolescent; Gasoline; Hallucinations; Hallucinogens; Humans; Lysergic Acid Diethylamide; Mental Disorders; Mescaline; Petroleum; Projective Techniques; Psilocybin; Psychophysiology; Psychoses, Substance-Induced; Psychotic Disorders; Toxicology | 1964 |
[FUNDAMENTALS OF A CONDITIONAL-GENETIC PSYCHOPATHOLOGY AS EXEMPLIFIED BY EXPERIMENTAL PSYCHOSIS].
Topics: Hallucinogens; Lysergic Acid Diethylamide; Mental Disorders; Mescaline; Neurotic Disorders; Psilocybin; Psychopathology; Psychotherapy; Psychotic Disorders; Toxicology | 1963 |
[SEROTONIN AND PSYCHIATRY].
Topics: Bipolar Disorder; Catecholamines; Drug Therapy; Hallucinations; Hallucinogens; Humans; Hydroxyindoleacetic Acid; Hypoglycemic Agents; Indoleacetic Acids; Lysergic Acid Diethylamide; Mescaline; Metabolism; Monoamine Oxidase Inhibitors; Phenothiazines; Psilocybin; Psychiatry; Psychotic Disorders; Research; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Serotonin | 1964 |
PATTERNS OF HALLUCINOGENIC DRUG ABUSE.
Topics: Amphetamine; Amphetamines; Barbiturates; Cannabis; Drug and Narcotic Control; Hallucinogens; Humans; Indoles; Lysergic Acid Diethylamide; Mescaline; Psilocybin; Psychoses, Substance-Induced; Psychotic Disorders; Sexual Behavior; Substance-Related Disorders; Toxicology | 1965 |
[A PSYCHOPATHOLOGICAL STUDY OF THE PSILOCYBIN PSYCHOSIS; COMPARISON WITH THE LSD-25 PSYCHOSIS].
Topics: Hallucinogens; Indoles; Lysergic Acid Diethylamide; Psilocybin; Psychopathology; Psychopharmacology; Psychotic Disorders; Research; Toxicology | 1964 |
THREE YEARS' EXPERIENCE WITH THE USE OF LSD AS AN AID IN PSYCHOTHERAPY.
Topics: Drug Therapy; Hallucinogens; Humans; Lysergic Acid Diethylamide; Mental Disorders; Neurotic Disorders; Prognosis; Psilocybin; Psychoanalytic Therapy; Psychotherapy; Psychotic Disorders | 1964 |
[Modification of the conditioning of evoked activities in man by combining sound and light, after the administration of psilocybine].
Topics: Conditioning, Psychological; Evoked Potentials; Humans; Light; Methods; Occipital Lobe; Psilocybin; Psychotic Disorders; Sound; Time Factors | 1971 |